Mashable is a global, multi-platform media and entertainment company.
Eli Roth, known for his groundbreaking contributions to the horror genre with films like Cabin Fever, Hostel, and the upcoming Thanksgiving, has launched a new media company, The Horror Section. This ...
With its heavy atmosphere, gory aesthetic and concept based on an iconic American holiday, Thanksgiving seems tailor-made for fans of slasher and contemporary horror cinema. The presence of Patrick ...
Screen Culture and KH Studios have been removed from YouTube's Partner Program following outcry over fake trailer ...
Director, writer, and actor Eli Roth is best known for his work in horror — directing so-called “splatter” films including Hostel, Cabin Fever, and Thanksgiving. He also memorably starred in Quentin ...
Help support the DJs, journalists, and staff of the station you love. Filmmaker, actor, and avowed cinephile Eli Roth is telling us all about his Italian sex comedy soundtrack retrospective, “Eli Roth ...
US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).
“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...
US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...
Tirzepatide was evaluated in two robust global clinical development programs. (Image Credits: Pexels) Eli Lilly and Company (India) on Thursday announced the launch of Mounjaro in single-dose vial ...
Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s drug regulator, it said on Thursday. Global demand for Lilly’s diabetes and ...
MNC pharma major Eli Lilly has launched Mounjaro (tirzepatide), a weekly injection for obesity and type 2 diabetes, after obtaining approval from India’s Central Drugs Standard Control ...